RNA Targeting Small Molecule Drug Discovery Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Predicted CAGR for the RNA Targeting Small Molecule Drug Discovery Market Over the Forecast Period of 2025 to 2034?
The RNA targeting small molecule drug discovery market has grown exponentially in recent years. It is projected to expand from $1.76 billion in 2024 to $2.14 billion in 2025, with a CAGR of 21.8%. The past growth has been driven by advancements in understanding disease genetics, discoveries in genomics and proteomics, challenges related to drug resistance, growing investment in biotechnology and pharmaceutical research, and the increasing prominence of RNA therapeutics.
The RNA targeting small molecule drug discovery market is set to grow exponentially, reaching $4.92 billion by 2029 at a CAGR of 23.1%. The market expansion will be fueled by advancements in RNA epigenetics research, RNA-seq and functional genomics, AI integration, patient-centric drug development, and the rise of exosome-mediated drug delivery. Notable trends include the emergence of RNA editing technologies, progress in CRISPR technology, technological innovations, advances in RNA biology, and increased RNA targeting for neurodegenerative diseases.
What External and Internal Drivers Are Contributing to the Growth of the rna targeting small molecule drug discovery Market’s Growth?
The rising prevalence of cancer, genetic disorders, and viral infections is anticipated to fuel the growth of the RNA-targeted small-molecule drug discovery market in the future. Cancer represents a group of diseases characterized by uncontrolled cell growth in the body. Viral infections are caused by viruses, tiny infectious agents that replicate only inside living cells. RNA-targeting drug discovery is employed to address cancer, genetic disorders, and viral infections, as these conditions are associated with genetic material dysfunction that can be treated using drugs developed through RNA-targeting methods. For example, in February 2024, a report from the World Health Organization indicated an estimated 20 million new cancer cases and 9.7 million deaths worldwide in 2022. Lung cancer was the most prevalent, with 2.5 million new cases (12.4%), followed by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million cases, 7.3%), and stomach cancer (970,000 cases, 4.9%). By 2050, the number of new cancer cases is projected to rise by 77%, surpassing 35 million annually. Thus, the increasing prevalence of cancer, genetic disorders, and viral infections is driving the RNA-targeted small-molecule drug discovery market.
Get Your Free Sample of the Global RNA Targeting Small Molecule Drug Discovery Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12480&type=smp
Who Are the Top Companies Driving Innovation and Growth in the RNA Targeting Small Molecule Drug Discovery Market?
Major companies operating in the RNA targeting small molecule drug discovery market include:
• F. Hoffmann-La Roche Ltd_x000D_
• Merck & Co. Inc_x000D_
• Bayer AG_x000D_
• Novartis AG_x000D_
• Sanofi SA_x000D_
What Key Trends Are Currently Impacting the RNA Targeting Small Molecule Drug Discovery Market’s Development?
Artificial intelligence (AI) integration is revolutionizing the small-molecule drug discovery market. Companies in this space are leveraging AI to accelerate drug discovery processes and maintain their market leadership. For instance, in May 2023, Google Cloud, the cloud computing division of Google, launched the Target and Lead Identification Suite and Multiomics Suite to enhance the drug discovery process. The Multiomics Suite expedites genetic data analysis, enabling precision medicine development, while the Target and Lead Identification Suite helps researchers analyze amino acid functions and predict protein structures.
Get Instant Access to the Global RNA Targeting Small Molecule Drug Discovery Market Report with Swift Delivery!
What Are the Major Segments of the RNA Targeting Small Molecule Drug Discovery Market and Their Role in Driving Growth?
The RNA targeting small molecule drug discovery market covered in this report is segmented –
1) By Target RNA Type: Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)
2) By Technology: CRISPR-Cas9, RNA Aptamers, Small Interfering RNA (siRNA), Ribozymes, Other Technologies
3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Metabolic Diseases, Genetic Disorders, Other Therapeutic Areas
4) By Delivery Method: Intravenous (IV), Oral, Topical, Other Methods
5) By Application: Research Use, Therapeutic Use, Diagnostic Use, Other Applications
Subsegments:
1) By Messenger RNA (mRNA): Targeting mRNA For Protein Coding, Modulation Of mRNA Stability, mRNA Translation Inhibition
2) By Non-Coding RNA (ncRNA): Long Non-Coding RNA, Small Nuclear RNA, Small Nucleolar RNA
3) By MicroRNA (miRNA): miRNA Inhibition, miRNA Mimics, Targeting Specific miRNA Pathways
4) By Long Non-Coding RNA (lncRNA): lncRNA Modulators, Targeting Specific lncRNA Functions, Therapeutic Applications Of lncRNA
Which Geographical Regions Are Pioneering Growth in the RNA Targeting Small Molecule Drug Discovery Market?
North America was the largest region in the RNA-targeting small molecule drug discovery market in 2024. The regions covered in the RNA targeting small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Key Characteristics That Define the RNA Targeting Small Molecule Drug Discovery Market?
RNA targeting small-molecule drug discovery refers to identifying and developing small-molecule drugs that interact with RNA molecules to modulate their function or activity. This process is used for discovering innovative medicines that would be used for treating various diseases, including genetic disorders, viral infections, neurodegenerative diseases, and cancer.
Browse Through More Similar Reports By The Business Research Company:
Drug Discovery Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report
Drug Discovery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report
Small Molecule Drug Discovery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
